Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting
Go back to Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting| Sunshine Biopharma, Inc. (NASDAQ: SBFM) | Delayed: 0.90 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.90 | 52 Week High | $0.04 | |||
| Open | $0.90 | 52 Week Low | $0.00 | |||
| Day High | $0.90 | P/E | N/A | |||
| Day Low | $0.90 | EPS | $0.00 | |||
| Volume | 4,051 | |||||
